Symbion Stockholders Approve Merger with an Affiliate of Crestview Partners, L.P.
15 August 2007 - 6:40PM
Business Wire
Symbion, Inc. (NASDAQ:SMBI) announced today that stockholders voted
to approve the merger agreement providing for the merger of Symbion
with an affiliate of Crestview Partners, L.P. Holders of
approximately 15.5 million shares of Symbion voted in favor of
approving the merger agreement and the transactions contemplated
thereby, representing approximately 71.2% of Symbion�s total
outstanding voting shares. Under the terms of the merger agreement,
Symbion stockholders will receive $22.35 per share in cash, without
interest, for each share of Symbion common stock held. The
transaction is expected to close in the third quarter of 2007,
subject to requisite regulatory approvals and other customary
closing conditions. About Symbion, Inc. Symbion, Inc.,
headquartered in Nashville, Tennessee, owns and operates a network
of 57 short stay surgical facilities in 23 states. Symbion�s
facilities provide non-emergency surgical procedures across many
specialties. About Crestview Partners, L.P. Crestview Partners,
L.P. is a $1.5 billion private equity firm established in 2004 by
former Goldman, Sachs & Co. partners Thomas S. Murphy, Jr. and
Barry S. Volpert. Crestview is backed by a sophisticated group of
investors, including many prominent entrepreneurs and institutions.
Crestview�s professionals have arranged more than $20 billion in
acquisitions and buyouts over the course of their careers,
including the 1989 management buyout of HCA Inc. and acquisitions
of Quorum Health Group and Westminster Healthcare. Forward Looking
Statements This press release contains forward-looking statements
based on management�s current expectations. These statements have
been included in reliance on the �safe harbor� provisions of the
Private Securities Litigation Reform Act of 1995. These statements
involve risks, uncertainties and other factors that may cause
actual results to differ from the expectations expressed in the
statements. Many of these factors are beyond the ability of Symbion
to control or predict. These factors include, without limitation:
(i) the occurrence of any event, change or other circumstances that
could give rise to the termination of the merger agreement; (ii)
the outcome of legal proceedings instituted against Symbion and
others following announcement of the merger agreement; (iii) the
inability to complete the merger; and (iv) the failure to obtain
the necessary debt financing arrangements for the merger. In light
of the significant uncertainties inherent in the forward-looking
statements contained in this press release, you should not place
undue reliance on them. Symbion undertakes no obligation to update
any forward-looking statements or to make any other forward-looking
statements, whether as a result of new information, future events
or otherwise.
Symbion (NASDAQ:SMBI)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Symbion (NASDAQ:SMBI)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Symbion (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Symbion, Inc. News-Artikel